Description

Boc-Lys(Z)-OH (DCHA) is a involves in synthesis thymosin β4, βg and β6 fragments, and increases E-rosette forming capacity in Lupus Nephritis model. Boc-Lys(Z)-OH (DCHA) involves in synthesis Boc-Lyz-OCH3 and acts as a reagent of peptidyl thrombin inhibitors production[1][2][3].—COVID-19-immunoregulation–C31H51N3O6—-[1]Abiko, et al. Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients. Chemical & pharmaceutical bulletin, 1984.|[2]Cal PM, et al. Iminoboronates: a new strategy for reversible protein modification. J Am Chem Soc. 2012 Jun 20;134(24):10299-305.|[3]Van Boeckel, et al. Preparation of peptidyl thrombin inhibitors: World Intellectual Property Organization, WO9807308. 1998-02-26. –16948-04-2–561.75—-O=C(O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(OCC1=CC=CC=C1)=O.C2(NC3CCCCC3)CCCCC2–Inflammation/Immunology–10 mM in DMSO–Amino Acid Derivatives—-Others–Peptides